Lv31
380 积分 2022-10-12 加入
Cancer incidence and mortality in China, 2022
1年前
已完结
Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy
1年前
已完结
Immune checkpoint therapy—current perspectives and future directions
1年前
已完结
[Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2022 edition)]
1年前
已完结
Combination of HER2-targeted agents with immune checkpoint inhibitors in the treatment of HER2-positive breast cancer
1年前
已完结
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial
1年前
已完结
Novel immunotherapies for breast cancer: Focus on 2023 findings
1年前
已完结
Prognostic value ofKRASmutations,TP53mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy
1年前
已完结
恶性肿瘤患者CT增强扫描对比剂安全管理专家共识（2022
1年前
已完结
[Chinese guideline for diagnosis and management of drug-induced liver injury (2023 version)]
1年前
已完结
皖公网安备34019202002308
